Hi Gekko, Remember that they only have an IDE for a pilot study. They will need to lodge another IDE for the pivotal study they will need the data from to lodge for market approval. The pivotal study (if approved by FDA) will likely cost them upwards of $15-20 million, require 300+ subjects and take 3-5 years to complete. They are therefore probably still the better part of another decade away from generating any revenue in the states...if the product is proven to work that is.
OSL Price at posting:
5.3¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)